inclusion criteria: * presenting with fever (≥37.5ºc) and/or one mild symptom suggestive of covid-19 disease (cough, dyspnoea, chills, odynophagia, diarrhoea, muscle pain, anosmia, taste disorder, headache) or contact of a sars-cov-2 confirmed or suspected case in the past 14 days * more than 12 weeks of gestation (dated by ultrasonography) * agreement to deliver in the study hospitals

inclusion criteria: * presenting with fever (≥37.5ºc) and/or one mild symptom suggestive of covid-19 disease (cough, dyspnoea, chills, odynophagia, diarrhoea, muscle pain, anosmia, taste disorder, headache) or contact of a sars-cov-2 confirmed or suspected case in the past 14 days * more than 12 weeks of gestation (dated by ultrasonography) * agreement to deliver in the study hospitals

inclusion criteria: - presenting with fever (≥37.5ºc) and/or one mild symptom suggestive of covid-19 disease (cough, dyspnoea, chills, odynophagia, diarrhoea, muscle pain, anosmia, taste disorder, headache) or contact of a sars-cov-2 confirmed or suspected case in the past 14 days - more than 12 weeks of gestation (dated by ultrasonography) - agreement to deliver in the study hospitals

inclusion criteria: - presenting with fever (≥37.5ºc) and/or one mild symptom suggestive of covid-19 disease (cough, dyspnoea, chills, odynophagia, diarrhoea, muscle pain, anosmia, taste disorder, headache) or contact of a sars-cov-2 confirmed or suspected case in the past 14 days - more than 12 weeks of gestation (dated by ultrasonography) - agreement to deliver in the study hospitals